Clinical trial
Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study
NCT00309283 · Mario Negri Institute for Pharmacological Research, Other · Completed
Key facts
| NCT number | NCT00309283 |
|---|---|
| Title | Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study |
| Official title | Effect of a Long-acting Somatostatin on Disease Progression in Nephropathy Due to Autosomal Dominant Polycystic Kidney Disease: a Long-term Three Year Follow up Study |
| Acronym | ALADIN |
| Lead sponsor | Mario Negri Institute for Pharmacological Research, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
| Intervention type | Drug, Other |
| Interventions | Long-acting somatostatin, Saline solution |
| Enrollment | 78 |
| Start date | Apr 1, 2006 |
| Primary completion | Jan 1, 2012 |
| Completion | Jan 1, 2012 |
| First posted | Mar 31, 2006 |
| Last update posted | Apr 24, 2013 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: